Eikon Therapeutics, Inc. (EIKN)
NASDAQ: EIKN · Real-Time Price · USD
8.56
-0.18 (-2.06%)
At close: Apr 28, 2026, 4:00 PM EDT
8.73
+0.17 (1.99%)
After-hours: Apr 28, 2026, 4:19 PM EDT
Eikon Therapeutics Analyst Ratings
Total Analysts
6
Consensus Rating
Buy
Price Target
$25.60
Upside
+199.07%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Wedbush | Wedbush | Sell Reiterates $7 | Sell | Reiterates | $7 | -18.22% | Mar 31, 2026 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Initiates n/a | Buy | Initiates | n/a | n/a | Mar 2, 2026 |
| JP Morgan | JP Morgan | Buy Initiates $29 | Buy | Initiates | $29 | +238.79% | Mar 2, 2026 |
| B of A Securities | B of A Securities | Strong Buy Initiates $34 | Strong Buy | Initiates | $34 | +297.20% | Mar 2, 2026 |
| Mizuho | Mizuho | Buy Initiates $26 | Buy | Initiates | $26 | +203.74% | Mar 2, 2026 |
| Morgan Stanley | Morgan Stanley | Buy Initiates $32 | Buy | Initiates | $32 | +273.83% | Mar 2, 2026 |
| Wedbush | Wedbush | Sell Initiates $7 | Sell | Initiates | $7 | -18.22% | Feb 26, 2026 |